Sheehan's syndrome natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
Iqra Qamar (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
* | *Sheehan syndrome, if left untreated lead to mitral regurgitation, pericardial effusion and diminished LVM.<ref name="pmid27359291">{{cite journal |vauthors=Laway BA, Ramzan M, Allai MS, Wani AI, Misgar RA |title=CARDIAC STRUCTURAL AND FUNCTIONAL ABNORMALITIES IN FEMALES WITH UNTREATED HYPOPITUITARISM DUE TO SHEEHAN SYNDROME: RESPONSE TO HORMONE REPLACEMENT THERAPY |journal=Endocr Pract |volume=22 |issue=9 |pages=1096–103 |year=2016 |pmid=27359291 |doi=10.4158/EP161262.OR |url=}}</ref> | ||
*Common complications of [disease name] include [complication 1], [complication 2], and [complication 3]. | *Common complications of [disease name] include [complication 1], [complication 2], and [complication 3]. | ||
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%. | *Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%. | ||
==Natural History, Complications, and Prognosis== | ==Natural History, Complications, and Prognosis== | ||
Revision as of 13:13, 11 August 2017
|
Sheehan's syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sheehan's syndrome natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Sheehan's syndrome natural history, complications and prognosis |
|
FDA on Sheehan's syndrome natural history, complications and prognosis |
|
CDC on Sheehan's syndrome natural history, complications and prognosis |
|
Sheehan's syndrome natural history, complications and prognosis in the news |
|
Blogs on Sheehan's syndrome natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
- Sheehan syndrome, if left untreated lead to mitral regurgitation, pericardial effusion and diminished LVM.[1]
- Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of [disease name] include:
- [complication 1]
- [complication 2]
- [complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Laway BA, Ramzan M, Allai MS, Wani AI, Misgar RA (2016). "CARDIAC STRUCTURAL AND FUNCTIONAL ABNORMALITIES IN FEMALES WITH UNTREATED HYPOPITUITARISM DUE TO SHEEHAN SYNDROME: RESPONSE TO HORMONE REPLACEMENT THERAPY". Endocr Pract. 22 (9): 1096–103. doi:10.4158/EP161262.OR. PMID 27359291.